Barinthus Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	70.46	110.66	142.09	194.39	214.05
Cash & Short-Term Investments	70.46	110.66	142.09	194.39	214.05
Cash Growth	-36.33%	-22.12%	-26.90%	-9.19%	394.74%
Accounts Receivable	-	-	-	5.85	0.02
Other Receivables	1.11	7.14	4.91	4.54	6.23
Total Trade Receivables	1.11	7.14	4.91	10.39	6.25
Other Current Assets	6.23	7.94	9.91	8.27	6.46
Total Current Assets	77.79	125.74	156.91	213.04	226.77
Net Property, Plant & Equipment	5.16	11.76	19.4	15.71	9.09
Other Intangible Assets	14.29	21.95	25.11	28.27	31.43
Goodwill	-	-	12.21	12.21	12.63
Other Long-Term Assets	0.93	0.88	0.88	0.98	0.8
Total Assets	98.17	160.33	214.51	270.21	280.72
Accounts Payable	0.35	2.47	1.6	3.75	2.42
Accrued Expenses	6.25	9.53	9.21	8.06	7.88
Short-Term Debt	-	-	-	-	0.16
Current Portion of Leases	2.02	1.92	1.79	0.43	0.52
Unearned Revenue	1.4	1.74	-	-	0.18
Total Current Liabilities	10.02	15.66	12.6	12.24	11.16
Long-Term Leases	9.26	10.09	11.19	8.34	6.54
Other Long-Term Liabilities	4.6	4.45	3.72	6.42	10.46
Total Long-Term Liabilities	13.86	14.54	14.91	14.76	17
Total Liabilities	23.88	30.19	27.51	27	28.15
Preferred Stock	0.09	0.09	0.09	0.09	0.09
Common Stock	0	0	0	0.01	0.01
Additional Paid-in Capital	393.94	393.47	386.6	379.5	369.1
Accumulated Other Comprehensive Income	-15.73	-25.87	-23.32	-33.46	-8.49
Retained Earnings	-304.09	-237.66	-176.59	-103.24	-108.59
Total Common Shareholders' Equity	74.21	130.03	186.78	242.9	252.13
Minority Interest	0.08	0.11	0.21	0.31	0.44
Shareholders' Equity	74.29	130.14	187	243.2	252.56
Total Liabilities & Equity	98.17	160.33	214.51	270.21	280.72
Total Debt	11.28	12.01	12.98	8.77	7.22
Net Cash (Debt)	59.18	98.66	129.11	185.61	206.83
Net Cash Growth	-40.02%	-23.59%	-30.44%	-10.26%	397.17%
Net Cash Per Share	1.46	2.51	3.36	4.86	7.99
Book Value	74.21	130.03	186.78	242.9	252.13
Book Value Per Share	1.83	3.30	4.87	6.36	9.74
Tangible Book Value	59.92	108.08	149.47	202.42	208.07
Tangible Book Value Per Share	1.48	2.75	3.89	5.30	8.04

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q